Curis Inc (CRIS)
14.70
-0.07
(-0.47%)
USD |
NASDAQ |
Apr 25, 11:34
Curis Free Cash Flow (Quarterly): -10.19M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.19M |
| September 30, 2023 | -8.181M |
| June 30, 2023 | -7.868M |
| March 31, 2023 | -12.20M |
| December 31, 2022 | -12.27M |
| September 30, 2022 | -13.17M |
| June 30, 2022 | -12.48M |
| March 31, 2022 | -16.83M |
| December 31, 2021 | -8.171M |
| September 30, 2021 | -9.61M |
| June 30, 2021 | -6.659M |
| March 31, 2021 | -13.18M |
| December 31, 2020 | -5.735M |
| September 30, 2020 | -6.035M |
| June 30, 2020 | -5.389M |
| March 31, 2020 | -9.257M |
| December 31, 2019 | -5.599M |
| September 30, 2019 | -6.704M |
| June 30, 2019 | -6.71M |
| March 31, 2019 | -7.233M |
| December 31, 2018 | -4.94M |
| September 30, 2018 | -8.231M |
| June 30, 2018 | -6.938M |
| March 31, 2018 | -10.04M |
| December 31, 2017 | -7.546M |
| Date | Value |
|---|---|
| September 30, 2017 | -16.50M |
| June 30, 2017 | -9.297M |
| March 31, 2017 | -15.20M |
| December 31, 2016 | -9.447M |
| September 30, 2016 | -7.596M |
| June 30, 2016 | -11.10M |
| March 31, 2016 | -7.995M |
| December 31, 2015 | -10.86M |
| September 30, 2015 | -4.516M |
| June 30, 2015 | -6.786M |
| March 31, 2015 | -7.774M |
| December 31, 2014 | -4.719M |
| September 30, 2014 | -2.092M |
| June 30, 2014 | -4.788M |
| March 31, 2014 | -5.306M |
| December 31, 2013 | -5.531M |
| September 30, 2013 | 0.1779M |
| June 30, 2013 | 0.0238M |
| March 31, 2013 | -4.363M |
| December 31, 2012 | -13.40M |
| September 30, 2012 | -4.189M |
| June 30, 2012 | -1.635M |
| March 31, 2012 | 3.927M |
| December 31, 2011 | 8.677M |
| September 30, 2011 | -4.428M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-16.83M
Minimum
Mar 2022
-5.389M
Maximum
Jun 2020
-9.276M
Average
-8.181M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Kura Oncology Inc | -34.32M |
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | -9.097M |
| Protalix BioTherapeutics Inc | 3.345M |
| Armata Pharmaceuticals Inc | -10.51M |